These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 9072554
1. p16 (CDKN2/MTS1) gene deletions are rare in prostatic carcinomas in the United States and Japan. Mangold KA, Takahashi H, Brandigi C, Wada T, Wakui S, Furusato M, Boyd J, Chandler FW, Allsbrook WC. J Urol; 1997 Mar; 157(3):1117-20. PubMed ID: 9072554 [Abstract] [Full Text] [Related]
5. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN. J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999 [Abstract] [Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R, Shiohara M, Koeffler HP, Fagin JA. Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724 [Abstract] [Full Text] [Related]
7. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Schmid M, Malicki D, Nobori T, Rosenbach MD, Campbell K, Carson DA, Carrera CJ. Oncogene; 1998 Nov 19; 17(20):2669-75. PubMed ID: 9840931 [Abstract] [Full Text] [Related]
8. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Kim JW, Namkoong SE, Ryu SW, Kim HS, Shin JW, Lee JM, Kim DH, Kim IK. Gynecol Oncol; 1998 Jul 19; 70(1):75-9. PubMed ID: 9698478 [Abstract] [Full Text] [Related]
12. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Cancer Res; 1997 Aug 01; 57(15):3126-30. PubMed ID: 9242437 [Abstract] [Full Text] [Related]
13. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga]. Larsen CJ. Bull Cancer; 1997 Apr 01; 84(4):427-30. PubMed ID: 9238169 [Abstract] [Full Text] [Related]
18. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A. Virchows Arch; 2002 Aug 01; 441(2):133-42. PubMed ID: 12189502 [Abstract] [Full Text] [Related]
19. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization. Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM. Genes Chromosomes Cancer; 1997 Jun 01; 19(2):84-9. PubMed ID: 9171998 [Abstract] [Full Text] [Related]